ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
5,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
8,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
9,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
10,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
12,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
14,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
15,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
16,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
17,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
18,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
